Chemokine receptor antagonists: part 2

JE Pease, R Horuk - Expert opinion on therapeutic patents, 2009 - Taylor & Francis
Background: The first part of this two-part review discussed approaches to generating
antagonists for some of the CC chemokine receptors, including CCR1, CCR2, CCR3, and …

Chemokine receptor antagonists: Part 1

JE Pease, R Horuk - Expert opinion on therapeutic patents, 2009 - Taylor & Francis
Background: Chemokines were originally defined as host defense proteins, however, their
biological role goes well beyond this simple description of their function as immune cell …

Chemokine receptor antagonists: overcoming developmental hurdles

R Horuk - Nature reviews Drug discovery, 2009 - nature.com
Chemokine receptors have a key role in the pathogenesis of autoimmune diseases,
inflammation and viral infection. However, with the exception of selective CCR5 antagonists …

CCR1 chemokine receptor antagonist

T Saeki, A Naya - Current pharmaceutical design, 2003 - ingentaconnect.com
The selective accumulation and activation of leukocytes in inflamed tissues contributes to
the pathogenesis of inflammatory and autoimmune diseases such as infection, rheumatoid …

Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists

A Palani, JR Tagat - Journal of medicinal chemistry, 2006 - ACS Publications
Human immunodeficiency virus (HIV) infection with its clinical progression to AIDS has
become one of the fatal diseases in the world and the leading cause of death in Africa. 1 …

CCR1 antagonists: what have we learned from clinical trials

RP Gladue, MF Brown… - Current topics in medicinal …, 2010 - ingentaconnect.com
The identification of chemokines and their receptors as potent mediators of leukocyte
infiltration raised interest in the potential role of these proteins on disease pathogenesis …

Chemokine receptor antagonists

J Pease, R Horuk - Journal of medicinal chemistry, 2012 - ACS Publications
Chemokines are small basic proteins that are defined by the number and position of the
invariant cysteines in their protein sequence. 1 At the time this review was written more than …

CCR5 antagonists for the treatment of HIV.

CG Barber - Current Opinion in Investigational Drugs (London …, 2004 - europepmc.org
The CCR5 chemokine receptor is expressed on a wide range of immune cell types and
binding to this receptor mediates cellular entry by the majority of HIV isolates. Blocking viral …

Development and evaluation of pharmacological agents targeting chemokine receptors

R Horuk - Methods, 2003 - Elsevier
Chemokine receptors belong to one of the most pharmacologically exploited proteins, the G-
protein-coupled receptors. Drugs that target these receptors make up greater than 45% of all …

[引用][C] Recent progress in the discovery of new CCR5 and CXCR4 chemokine receptor antagonists as inhibitors of HIV-1 entry. Part 2

WM Kazmierski, JP Peckham, M Duan… - … -Anti-Infective Agents, 2005 - ingentaconnect.com
Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor
Antagonists as Inhibitors of HIV-1 Entry. Part 2* Page 1 Curr. Med. Chem. - Anti-Infective …